Literature DB >> 11349026

Effects of superantigen and lipopolysaccharide on induction of CD80 through apoptosis of human monocytes.

M Takahashi1, M Takahashi1, F Shinohara, H Takada, H Rikiishi.   

Abstract

To investigate the mechanisms underlying superantigen (SAg) stimulation, we analyzed the effect of SAg on monocyte responses with or without lipopolysaccharide (LPS). Addition of gamma interferon (IFN-gamma) to unstimulated cultures induced a marked increase in the number of CD80(+) monocytes, which was inhibited by LPS through the action of interleukin-10. However, CD80(+) monocytes began to increase before IFN-gamma production, observed after 9 h of stimulation with staphylococcal enterotoxin B (SEB). SEB selectively increased the number of apoptotic CD80(-) monocytes, whereas LPS-treated monocytes were resistant to the apoptotic action of SEB. This SEB-induced killing was abrogated by anti-CD95 monoclonal antibody (MAb) ZB4 and anti-CD95 ligand (CD95L) MAb NOK2, suggesting a CD95-based pathway of apoptosis. Furthermore, the numbers of SEB-induced CD80(+) monocytes were partially decreased by anti-CD119 (IFN-gamma receptor) MAb and by anti-CD95L (NOK2) MAb. The CD30 expression of CD27(high) T cells induced by SEB was increased by agonistic anti-CD95 (CH11) MAb. Together, our findings showed that SEB-induced monocyte apoptosis is closely associated with the enrichment of CD80(+) monocytes generated before IFN-gamma production, followed by up-regulation of CD80 by IFN-gamma, and that LPS has negative effects in both cases. These results also suggested that induction of monocyte apoptosis is an important mechanism by which SAg exerts its anti-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349026      PMCID: PMC98359          DOI: 10.1128/IAI.69.6.3652-3657.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes.

Authors:  D F Mangan; B Robertson; S M Wahl
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

2.  Induction of human TCR gamma delta + and TCR gamma delta-CD2+CD3- double negative lymphocytes by bacterial stimulation.

Authors:  T Abo; S Sugawara; S Seki; M Fujii; H Rikiishi; K Takeda; K Kumagai
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

3.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors:  L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

4.  Lipopolysaccharide-dependent down-regulation of CD27 expression on T cells activated with superantigen.

Authors:  K Kai; H Rikiishi; S Sugawara; M Takahashi; H Takada; K Kumagai
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

5.  Differential regulation of IL-1 production in human monocytes by IFN-gamma and IL-4.

Authors:  R P Donnelly; M J Fenton; D S Finbloom; T L Gerrard
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

6.  Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4.

Authors:  A N Schweitzer; A H Sharpe
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

Review 7.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.

Authors:  F Willems; A Marchant; J P Delville; C Gérard; A Delvaux; T Velu; M de Boer; M Goldman
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

9.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

10.  Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes.

Authors:  D F Mangan; G R Welch; S M Wahl
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

View more
  6 in total

Review 1.  The retrovirus/superantigen hypothesis of multiple sclerosis.

Authors:  Alexander Emmer; Martin S Staege; Malte E Kornhuber
Journal:  Cell Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.046

2.  Interleukin-1beta converting enzyme subfamily inhibitors prevent induction of CD86 molecules by butyrate through a CREB-dependent mechanism in HL60 cells.

Authors:  M Suzuki; F Shinohara; K Sato; T Taniguchi; H Takada; H Rikiishi
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

3.  Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates.

Authors:  S Holtfreter; D Grumann; M Schmudde; H T T Nguyen; P Eichler; B Strommenger; K Kopron; J Kolata; S Giedrys-Kalemba; I Steinmetz; W Witte; B M Bröker
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

4.  Effects of CTLA4-Ig on human monocytes.

Authors:  Toshihiro Tono; Satoko Aihara; Takayuki Hoshiyama; Yoshiyuki Arinuma; Tatsuo Nagai; Shunsei Hirohata
Journal:  Inflamm Regen       Date:  2017-11-06

5.  egc Superantigens Impair Monocytes/Macrophages Inducing Cell Death and Inefficient Activation.

Authors:  Sofia Noli Truant; Mauricio C De Marzi; María B Sarratea; María B Antonoglou; Ana P Meo; Laura V Iannantuono López; María J Fernández Lynch; Marcos Todone; Emilio L Malchiodi; Marisa M Fernández
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

Review 6.  Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?

Authors:  Henning M Schramm
Journal:  J Cancer       Date:  2014-01-15       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.